Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 15;390(7):662-663.
doi: 10.1056/NEJMe2314434.

Silencing Immune Dialogue in Multiple Sclerosis

Affiliations
Editorial

Silencing Immune Dialogue in Multiple Sclerosis

Stephen L Hauser. N Engl J Med. .
No abstract available

PubMed Disclaimer

References

    1. Vermersch P, Granziera C, Mao-Draayer Y, et al. Inhibition of CD40L with Frexalimab in Multiple Sclerosis. N Engl J Med 2024. - PubMed
    1. Smets I, Fiddes B, Garcia-Perez JE, et al. Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells. Brain 2018;141:786–96. - PMC - PubMed
    1. Li R, Rezk A, Miyazaki Y, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med 2015;7:310ra166. - PubMed
    1. Khoury SJ, Rochon J, Ding L, et al. ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Mult Scler 2017;23:686–95. - PMC - PubMed
    1. Kappos L, Hartung HP, Freedman MS, et al. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Neurol 2014;13:353–63. - PubMed

Publication types

MeSH terms